You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Exercise Disclosure
Kelly Thomas Patrick · SEC Form 4 · Filed Oct 16, 2026
Exercise
Reported value range
Not reported
Kelly Thomas Patrick Chief Financial Officer
XENE
Transaction date
Oct 15, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 1 day later
XENE daily price context
Close on/before transaction
$34.33
Oct 15, 2026
First close after public filing
$35.08
Oct 19, 2026
Return after filing · so far
+20.04%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 7,500 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-424428
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE Current | Exercise | Oct 15, 2026 | Not reported |
| Xenon Pharmaceuticals Inc. XENE | Exercise | Oct 15, 2026 | $0 |